Fatty acid formulations and methods of use thereof
First Claim
Patent Images
1. A dietary formulation suitable for treating an autism spectrum disorder and/or apraxia, the formulation comprising:
- a) eicosapentaenoic acid (EPA);
b) docosohexaenoic acid (DHA);
c) α
-tocopherol;
d) γ
-tocopherol;
e) vitamin K1;
f) vitamin K2; and
g) γ
-linolenic acid (GLA),wherein the ratio of EPA to DHA is in a range of from 1.5;
1 to 5;
1,wherein the α
-tocopherol is present in an amount of from 300 mg to 3000 mg per unit dose,wherein the γ
-tocopherol is present in an amount of from 200 mg to 1000 mg per unit dose,wherein the EPA is present in an amount of from 500 mg to 3000 mg per unit dose,wherein the DHA is present in an amount of from 100 mg to 400 mg per unit dose,wherein the vitamin K1 is present in an amount of from 100 μ
g to 10 mg,wherein the vitamin K2 is present in an amount of from 100 μ
g to 2 mg; and
wherein the GLA is present in an amount of from 50 mg to 75 mg.
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention provides dietary formulations comprising polyunsaturated fatty acids and vitamin E. The present invention further provides methods of treating various conditions, generally involving administering to an individual in need thereof an effective amount of a subject dietary formulation.
-
Citations
28 Claims
-
1. A dietary formulation suitable for treating an autism spectrum disorder and/or apraxia, the formulation comprising:
-
a) eicosapentaenoic acid (EPA); b) docosohexaenoic acid (DHA); c) α
-tocopherol;d) γ
-tocopherol;e) vitamin K1; f) vitamin K2; and g) γ
-linolenic acid (GLA),wherein the ratio of EPA to DHA is in a range of from 1.5;
1 to 5;
1,wherein the α
-tocopherol is present in an amount of from 300 mg to 3000 mg per unit dose,wherein the γ
-tocopherol is present in an amount of from 200 mg to 1000 mg per unit dose,wherein the EPA is present in an amount of from 500 mg to 3000 mg per unit dose, wherein the DHA is present in an amount of from 100 mg to 400 mg per unit dose, wherein the vitamin K1 is present in an amount of from 100 μ
g to 10 mg,wherein the vitamin K2 is present in an amount of from 100 μ
g to 2 mg; andwherein the GLA is present in an amount of from 50 mg to 75 mg. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
-
Specification